Civic Intelligence

Fund for Ophthalmic Knowledge Inc C/O David H Abramson MD

990 • Fiscal year 2023 • EIN 13-4171637

Jan 01, 2023 to Dec 31, 2023 • Filed on May 16, 2024

101 Central Park WestNew York, NY 10023

(212) 744-1700

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

63rd percentile

0.09x

Higher debt load relative to assets than 63% of similar nonprofits.

2023 filings • NTEE A • $500k-$1M nonprofits • Source year 2023

Liabilities / Revenue

96th percentile

1.36x

Higher debt load relative to revenue than 96% of similar nonprofits.

2023 filings • NTEE A • $500k-$1M nonprofits • Source year 2023

Net Margin

2nd percentile

-385%

Higher net margin than 2% of similar nonprofits.

2023 filings • NTEE A • $500k-$1M nonprofits • Source year 2023

Top Officer Pay

51st percentile

$0

Higher top officer pay than 51% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2023 filings • NTEE A • $500k-$1M nonprofits • Source year 2023

Asset Growth

17th percentile

-16%

Faster asset growth than 17% of similar nonprofits.

2023 filings • NTEE A • $500k-$1M nonprofits • Annualized from 2022 to 2023

Revenue Growth

6th percentile

-50%

Faster revenue growth than 6% of similar nonprofits.

2023 filings • NTEE A • $500k-$1M nonprofits • Annualized from 2022 to 2023

Assets

Flat

$814,715

Flat from 2023

Net Assets

Flat

$743,740

Flat from 2023

Liabilities

Flat

$70,975

Flat from 2023

Revenue

Flat

$52,140

Flat from 2023

Expenses

Flat

$252,639

Flat from 2023

Net Income

Flat

-$200,499

Flat from 2023

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$2.0M$1.5M$1.0M$500K$0Assets 2010: $1,740,160Liabilities 2010: $1,640Net Assets 2010: $1,738,5202010Assets 2011: $1,579,697Liabilities 2011: $0Net Assets 2011: $1,579,6972011Assets 2012: $1,531,585Liabilities 2012: $0Net Assets 2012: $1,531,5852012Assets 2013: $1,443,299Liabilities 2013: $350Net Assets 2013: $1,442,9492013Assets 2014: $1,686,054Liabilities 2014: $320Net Assets 2014: $1,685,7342014Assets 2015: $1,614,837Liabilities 2015: $30,076Net Assets 2015: $1,584,7612015Assets 2016: $1,547,032Liabilities 2016: $8,215Net Assets 2016: $1,538,8172016Assets 2017: $1,554,628Liabilities 2017: $8,976Net Assets 2017: $1,545,6522017Assets 2018: $1,267,942Liabilities 2018: $9,448Net Assets 2018: $1,258,4942018Assets 2019: $1,281,127Liabilities 2019: $12,516Net Assets 2019: $1,268,6112019Assets 2020: $1,222,644Liabilities 2020: $9,712Net Assets 2020: $1,212,9322020Assets 2021: $1,296,631Liabilities 2021: $7,022Net Assets 2021: $1,289,6092021Assets 2022: $965,576Liabilities 2022: $99,999Net Assets 2022: $865,5772022Assets 2023: $814,715Liabilities 2023: $70,975Net Assets 2023: $743,7402023Assets 2023: $814,715Liabilities 2023: $70,975Net Assets 2023: $743,7402023Assets 2024: $776,581Liabilities 2024: $58,079Net Assets 2024: $718,5022024

Highlighted filing

2023

Assets$814,715
Liabilities$70,975
Net Assets$743,740

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KRevenue 2010: $479,973Expenses 2010: $488,766Net Income 2010: -$8,7932010Expenses 2011: $500,1082011Expenses 2012: $541,3932012Revenue 2013: $384,711Expenses 2013: $654,602Net Income 2013: -$269,8912013Revenue 2014: $518,057Expenses 2014: $259,116Net Income 2014: $258,9412014Revenue 2015: $418,944Expenses 2015: $447,087Net Income 2015: -$28,1432015Revenue 2016: $168,796Expenses 2016: $236,223Net Income 2016: -$67,4272016Revenue 2017: $213,415Expenses 2017: $313,822Net Income 2017: -$100,4072017Revenue 2018: $206,065Expenses 2018: $318,097Net Income 2018: -$112,0322018Revenue 2019: $159,430Expenses 2019: $294,025Net Income 2019: -$134,5952019Revenue 2020: $74,344Expenses 2020: $196,561Net Income 2020: -$122,2172020Revenue 2021: $183,014Expenses 2021: $139,882Net Income 2021: $43,1322021Revenue 2022: $104,640Expenses 2022: $255,319Net Income 2022: -$150,6792022Revenue 2023: $52,140Expenses 2023: $252,639Net Income 2023: -$200,4992023Revenue 2023: $52,140Expenses 2023: $252,639Net Income 2023: -$200,4992023Revenue 2024: $69,628Expenses 2024: $135,928Net Income 2024: -$66,3002024

Highlighted filing

2023

Revenue$52,140
Expenses$252,639
Net Income-$200,499
Jump To
Filing Snapshot
Filing Period
Jan 1, 2023 to Dec 31, 2023
Signed
May 16, 2024
Return Version
2023v5.0
Gross Receipts
$476,923
Mission and Program Overview

Mission

See statement on schedule o

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments Other Securities$826,000$730,478▼ $95,522
Cash and Non-Interest-Bearing Accounts$127,307$82,374▼ $44,933
Prepaid Expenses and Deferred Charges$9,768--
Land, Buildings, and Equipment, Net$2,501$1,863▼ $638
Total Assets$965,576$814,715▼ $150,861
Other Assets Total$0$0→ $0
Liabilities
Other Liabilities$99,999$70,975▼ $29,024
Total Liabilities$99,999$70,975▼ $29,024
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$865,577$743,740▼ $121,837
Total Net Assets Fund Balance$865,577$743,740▼ $121,837
Total Liabilities and Net Assets / Fund Balance$965,576$814,715▼ $150,861

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$1,863$8,580$10,443
Other Securities$730,478--
Compensation and Service Providers

Board Members and Trustees

NameTitle
David H Abramson MdDirector & President
Allan Abramson MdDirector
Joseph Gold MdDirector
Nicholas Grumbach MdDirector
Hilary Cruz-abrams BamphrnDirector & Treasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$34,922
Program Service Revenue
$0
Investment Income
$17,218
Other Revenue
$0
All Other Contributions
$34,922
Change in Net Assets
$-200,499
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$247,857
Other Expenses$4,782
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$210,546--$210,546
Grants to Domestic Individuals$29,811--$29,811
Foreign Grants$7,500--$7,500
Office Expenses-$1,183-$1,183
Fees for Service Investment Mgmnt Fees-$701-$701
Depreciation Depletion-$638-$638
Other Expenses-$568-$568
Total Functional Expenses$247,857$4,782$0$252,639
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Memorial Sloan Kettering Cancer CenterNew York, NY501(c)(3)SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.$198,692

International Summary

Offices
0
Employees
0
Spending
$0

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Credit Card Payable$70,850
State Filing Fee$125
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 2

David h. Abramson, m.d. And allan abramson, m.d. Are brothers. Hilary cruz-abrams is the daughter of david h. Abramson, m.d..

Form 990, Part VI, Section A, Line 8B

The organization does not maintain individual committees of the board. All actions are reviewed by the full board.

Form 990, Part VI, Section B, Line 11B

The form 990 will be distributed to the members of the board of directors as a matter of policy prior to it's being filed. Board members are required to review and approve the form 990 within seven days of receipt. Any questions raised are forwarded to the accountant for resolution.

Form 990, Part VI, Section B, Line 12C

To ensure that the fund operates in a manner consistent with its charitable purposes and does not engage in activities that could jeopardize its tax-exempt status, all officers and directors are required to complete conflict of interest questionnaire annually which is reviewed by the board to ensure no conflicts exist.

Form 990, Part VI, Section B, Line 15

No compensation has been made to any officers to date.

Form 990, Part VI, Section C, Line 19

The foundation makes its governing documents, conflict of interest policy, and financial statements available to the public upon written request.

Filing and Contact Details

Filer

Filer Name
Fund for Ophthalmic Knowledge Inc
EIN
13-4171637
Phone
2127441700
Address
101 CENTRAL PARK WEST, NEW YORK, NY 10023

Signing Officer

Name
David H Abramson Md
Title
President
Phone
2127441700
Signed
2024-05-16
Discuss with paid preparer
Yes

Organization Details

Principal Officer
David H Abramson Md
Formed
2001
Legal Domicile
Ny
Voting Board Members
5
Independent Board Members
5
Employees
0
Volunteers
0

Preparer

Firm
Lachman & Lachman Llp
Address
444 MADISON AVENUE SUITE 301, NEW YORK, NY 10022
Preparer
Paul Lachman
Phone
2123718319
Supplemental Narrative

Additional Explanations

Form 990, Part XII, Line 2C

The process has not changed from prior years.

FORM 990, PART I, LINE 1 & PART III, LINE 1:

The fund for ophthalmic knowledge, inc. (the fund) is a not-for-profit organization incorporated in the state of delaware under the not-for-profit corporation law and is exempt from federal income tax under section 501(c)(3) of the internal revenue code. Research: the fund was established to support basic research, clinical research and clinical trials by funding scientists, clinical researchers, technicians and/or students who work under the supervision of faculty members of medical schools or teaching hospitals, or are employees of research laboratories. Professional education: the fund supports efforts that educate and train technicians, medical students, physicians, nurses and nurses in training, scientists-in-training, post-doctoral and post-graduate fellows in ophthalmology and other areas of medicine. It supports the coordination of medical knowledge in field related to ophthalmology including medicine, pediatrics, surgery radiation oncology, pathology, genetics and neurosurgery, public education: the fund supports educational efforts directed at the general public through the use of oral and written material and video in english and other languages in addition to computer based learning and internet based dissemination of knowledge. Technology: the fund supports the initiation, development, integration, and use of new technology in ophthalmology and other fields of medicine that are used in the diagnosis, documentation, treatment, or genetic understanding of diseases. The fund may offer a scholarship to assist medical students, doctoral students, doctors-in-training and nurses with educational expenses incurred attending courses or conferences. The selection criteria will be objective and non-discriminatory.

Raw XML AppendixShowing 400 of 423 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0SEE STATEMENT ON SCHEDULE O
IRS990/AllOtherContributionsAmt034922
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0FUND FOR OPHTHALMIC KNOWLEDGE INC
IRS990/BooksInCareOfDetail/PhoneNum02127441700
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0101 CENTRAL PARK WEST
IRS990/BooksInCareOfDetail/USAddress/CityNm0NEW YORK
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990/BooksInCareOfDetail/USAddress/ZIPCd010023
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0127307
IRS990/CashNonInterestBearingGrp/EOYAmt082374
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt034922
IRS990/CYGrantsAndSimilarPaidAmt0247857
IRS990/CYInvestmentIncomeAmt017218
IRS990/CYOtherExpensesAmt04782
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-200499
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0252639
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt052140
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt0638
IRS990/DepreciationDepletionGrp/TotalAmt0638
IRS990/Desc0MEMORIAL SLOAN-KETTERING CANCER CENTER ("MSKCC") ($198,692) - SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRAARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0198692
IRS990/FamilyOrBusinessRlnInd01
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt0701
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt0701
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt07500
IRS990/ForeignGrantsGrp/TotalAmt07500
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt10.30
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt20.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt30.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt40.20
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/PersonNm0DAVID H ABRAMSON MD
IRS990/Form990PartVIISectionAGrp/PersonNm1ALLAN ABRAMSON MD
IRS990/Form990PartVIISectionAGrp/PersonNm2NICHOLAS GRUMBACH MD
IRS990/Form990PartVIISectionAGrp/PersonNm3HILARY CRUZ-ABRAMS BAMPHRN
IRS990/Form990PartVIISectionAGrp/PersonNm4JOSEPH GOLD MD
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/TitleTxt0DIRECTOR & PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR & TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02001
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt02046
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GrantAmt0198692
IRS990/GrantsToDomesticIndividualsGrp/ProgramServicesAmt029811
IRS990/GrantsToDomesticIndividualsGrp/TotalAmt029811
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0210546
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0210546
IRS990/GrantsToIndividualsInd01
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt0426829
IRS990/GrossReceiptsAmt0476923
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt05
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InvestmentIncomeGrp/ExclusionAmt015172
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt015172
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsOtherSecuritiesGrp/BOYAmt0826000
IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt0730478
IRS990/IRPDocumentCnt01
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt08580
IRS990/LandBldgEquipBasisNetGrp/BOYAmt02501
IRS990/LandBldgEquipBasisNetGrp/EOYAmt01863
IRS990/LandBldgEquipCostOrOtherBssAmt010443
IRS990/LegalDomicileStateCd0NY
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt0424783
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd00
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0SEE STATEMENT ON SCHEDULE O
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt0865577
IRS990/NetAssetsOrFundBalancesEOYAmt0743740
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt02046
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt02046
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt078662
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt0865577
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt0743740
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt01183
IRS990/OfficeExpensesGrp/TotalAmt01183
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt00
IRS990/OtherAssetsTotalGrp/EOYAmt00
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0RESEARCH EXPENSES
IRS990/OtherExpensesGrp/Desc1STATE FILING FEES
IRS990/OtherExpensesGrp/Desc2FOREIGN TAX
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt01000
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt1692
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt2568
IRS990/OtherExpensesGrp/TotalAmt01000
IRS990/OtherExpensesGrp/TotalAmt1692
IRS990/OtherExpensesGrp/TotalAmt2568
IRS990/OtherLiabilitiesGrp/BOYAmt099999
IRS990/OtherLiabilitiesGrp/EOYAmt070975
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt09768
IRS990/PrincipalOfficerNm0DAVID H ABRAMSON MD
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0MEETINGS AND EDUCATIONAL SUPPORT ($29,811) - TRAVEL, LODGING, AND BOARDING FOR MSK ATTENDINGS, MSK TECHNICIAN, INTERNS AND SUPPORT FOR SCIENTIFIC MEETINGS.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt029811
IRS990/ProgSrvcAccomActy2Grp/GrantAmt029811
IRS990/ProgSrvcAccomActy3Grp/Desc0MACULA SOCIETY EDUCATIONAL FUND ($10,000) - TO FUND VARIOUS EDUCATIONAL INITIATIVES.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt010000
IRS990/ProgSrvcAccomActy3Grp/GrantAmt010000
IRS990/ProgSrvcAccomActyOtherGrp/Desc0FUNDACION NATALI DAFNE FLEXER ($7,500) - SUPPORT CLINIC & MOLECULAR STUDIES OF RETINOBLASTOMA RESEARCH UNDER DIRECT OF DR. GUILLERMO CHANTADA, MD. PHD. THIS SUPPORTS RETINOBLASTOMA RESEARCH IN ARGENTINA AND SPAIN INCLUDING SUPPORT FOR LAB PERSONNEL, ATTENDANCE AT MEETINGS, SUPPLIES AND PUBLICATION.
IRS990/ProgSrvcAccomActyOtherGrp/Desc1RYR-1 FOUNDATION ($1,854) - TO FURTHER RYR-1 FOUNDATION'S MISSION OF INCREASING AWARENESS OF RYR-1 MYOPATHY, SUPPORTING RESEARCH, AND HELPING TO FIND A CURE.
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt07500
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt11854
IRS990/ProgSrvcAccomActyOtherGrp/GrantAmt07500
IRS990/ProgSrvcAccomActyOtherGrp/GrantAmt11854
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt045332
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0242738
IRS990/PYInvestmentIncomeAmt059308
IRS990/PYOtherExpensesAmt012581
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-150679
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt0255319
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt0104640
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-200499
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd01
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt09922
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt020332
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt017115
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt010786
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt050727
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0108882
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt014547
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt024722
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt027703
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt015814
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt021239
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0104025
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.38830
IRS990ScheduleA/PublicSupportPY170Pct00.38180
IRS990ScheduleA/PublicSupportTotal170Amt082672
IRS990ScheduleA/SubstantialContributorsTotAmt026210
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt09922
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt020332
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt017115
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt010786
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt050727
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0108882
IRS990ScheduleA/TotalSupportAmt0212907
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/EquipmentGrp/BookValueAmt01863
IRS990ScheduleD/EquipmentGrp/DepreciationAmt08580
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt010443
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt070850
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt1125
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0CREDIT CARD PAYABLE
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc1STATE FILING FEE
IRS990ScheduleD/OtherSecuritiesGrp/BookValueAmt0730478
IRS990ScheduleD/OtherSecuritiesGrp/Desc0PUBLICLY TRADED SECURITIES
IRS990ScheduleD/OtherSecuritiesGrp/MethodValuationCd0F
IRS990ScheduleD/TotalBookValueLandBuildingsAmt01863
IRS990ScheduleD/TotalBookValueSecuritiesAmt0730478
IRS990ScheduleD/TotalLiabilityAmt070975
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt00
IRS990ScheduleF/ContinuationTotalEmployeeCnt00
IRS990ScheduleF/ContinuationTotalOfficeCnt00
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd01
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt07500
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt0EFT
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/NonCashAssistanceAmt00
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt0FUNDACION NATALI DAFNE FLEXER - SUPPORT CLINIC & MOLECULAR STUDIES OF RETINOBLASTOMA RESEARCH UNDER DIRECT OF DR. GUILLERMO CHANTADA, MD. PHD. THIS SUPPORTS RETINOBLASTOMA RESEARCH IN ARGENTINA AND SPAIN INCLUDING SUPPORT FOR LAB PERSONNEL, ATTENDANCE AT MEETINGS, SUPPLIES AND PUBLICATION.
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt0SOUTH AMERICA - ARGENTINA
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/ValuationMethodUsedDesc0BOOK
IRS990ScheduleF/InterestInForeignTrustInd00
IRS990ScheduleF/PassiveForeignInvestmestCoInd00
IRS990ScheduleF/SubtotalEmployeesCnt00
IRS990ScheduleF/SubtotalOfficesCnt00
IRS990ScheduleF/SubtotalSpentAmt00
IRS990ScheduleF/Total501c3OrgCnt01
IRS990ScheduleF/TotalEmployeeCnt00
IRS990ScheduleF/TotalOfficeCnt00
IRS990ScheduleF/TotalSpentAmt00
IRS990ScheduleF/TransferToForeignCorpInd00
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/GrantTypeTxt0TRAVEL, LODGING, AND BOARDING FOR MSK ATTENDINGS, MSK TECHNICIAN, INTERNS AND SUPPORT FOR SCIENTIFIC MEETINGS.
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/NonCashAssistanceAmt029811
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/NonCashAssistanceDesc0AIRFARE, LODGING AND RESEARCH SUPPLIES EXPENSES WERE PAID DIRECTLY BY THE ORGANIZATION FOR SCIENTIFIC MEETINGS.
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/RecipientCnt07
IRS990ScheduleI/GrantsOtherAsstToIndivInUSGrp/ValuationMethodUsedDesc0BOOK
IRS990ScheduleI/RecipientTable/CashGrantAmt0198692
IRS990ScheduleI/RecipientTable/IRCSectionDesc0501(C)(3)
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt00
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0MEMORIAL SLOAN KETTERING CANCER CENTER
IRS990ScheduleI/RecipientTable/RecipientEIN0131624182
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt01275 YORK AVENUE
IRS990ScheduleI/RecipientTable/USAddress/CityNm0NEW YORK
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0NY
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd010065
IRS990ScheduleI/RecipientTable/ValuationMethodUsedDesc0BOOK
IRS990ScheduleI/SupplementalInformationDetail/ExplanationTxt0THE ORGANIZATION MONITORS THE USE OF THE GRANT FUNDS IN THE UNITED STATES BY REQUESTING REPORTS FROM THE RECIPIENTS OF THE GRANTS.
IRS990ScheduleI/SupplementalInformationDetail/FormAndLineReferenceDesc0PART I, LINE 2:
IRS990ScheduleI/Total501c3OrgCnt01
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DAVID H. ABRAMSON, M.D. AND ALLAN ABRAMSON, M.D. ARE BROTHERS. HILARY CRUZ-ABRAMS IS THE DAUGHTER OF DAVID H. ABRAMSON, M.D..
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1THE ORGANIZATION DOES NOT MAINTAIN INDIVIDUAL COMMITTEES OF THE BOARD. ALL ACTIONS ARE REVIEWED BY THE FULL BOARD.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2THE FORM 990 WILL BE DISTRIBUTED TO THE MEMBERS OF THE BOARD OF DIRECTORS AS A MATTER OF POLICY PRIOR TO IT'S BEING FILED. BOARD MEMBERS ARE REQUIRED TO REVIEW AND APPROVE THE FORM 990 WITHIN SEVEN DAYS OF RECEIPT. ANY QUESTIONS RAISED ARE FORWARDED TO THE ACCOUNTANT FOR RESOLUTION.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3TO ENSURE THAT THE FUND OPERATES IN A MANNER CONSISTENT WITH ITS CHARITABLE PURPOSES AND DOES NOT ENGAGE IN ACTIVITIES THAT COULD JEOPARDIZE ITS TAX-EXEMPT STATUS, ALL OFFICERS AND DIRECTORS ARE REQUIRED TO COMPLETE CONFLICT OF INTEREST QUESTIONNAIRE ANNUALLY WHICH IS REVIEWED BY THE BOARD TO ENSURE NO CONFLICTS EXIST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4NO COMPENSATION HAS BEEN MADE TO ANY OFFICERS TO DATE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5THE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON WRITTEN REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6THE PROCESS HAS NOT CHANGED FROM PRIOR YEARS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt7THE FUND FOR OPHTHALMIC KNOWLEDGE, INC. (THE FUND) IS A NOT-FOR-PROFIT ORGANIZATION INCORPORATED IN THE STATE OF DELAWARE UNDER THE NOT-FOR-PROFIT CORPORATION LAW AND IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. RESEARCH: THE FUND WAS ESTABLISHED TO SUPPORT BASIC RESEARCH, CLINICAL RESEARCH AND CLINICAL TRIALS BY FUNDING SCIENTISTS, CLINICAL RESEARCHERS, TECHNICIANS AND/OR STUDENTS WHO WORK UNDER THE SUPERVISION OF FACULTY MEMBERS OF MEDICAL SCHOOLS OR TEACHING HOSPITALS, OR ARE EMPLOYEES OF RESEARCH LABORATORIES. PROFESSIONAL EDUCATION: THE FUND SUPPORTS EFFORTS THAT EDUCATE AND TRAIN TECHNICIANS, MEDICAL STUDENTS, PHYSICIANS, NURSES AND NURSES IN TRAINING, SCIENTISTS-IN-TRAINING, POST-DOCTORAL AND POST-GRADUATE FELLOWS IN OPHTHALMOLOGY AND OTHER AREAS OF MEDICINE. IT SUPPORTS THE COORDINATION OF MEDICAL KNOWLEDGE IN FIELD RELATED TO OPHTHALMOLOGY INCLUDING MEDICINE, PEDIATRICS, SURGERY RADIATION ONCOLOGY, PATHOLOGY, GENETICS AND NEUROSURGERY, PUBLIC EDUCATION: THE FUND SUPPORTS EDUCATIONAL EFFORTS DIRECTED AT THE GENERAL PUBLIC THROUGH THE USE OF ORAL AND WRITTEN MATERIAL AND VIDEO IN ENGLISH AND OTHER LANGUAGES IN ADDITION TO COMPUTER BASED LEARNING AND INTERNET BASED DISSEMINATION OF KNOWLEDGE. TECHNOLOGY: THE FUND SUPPORTS THE INITIATION, DEVELOPMENT, INTEGRATION, AND USE OF NEW TECHNOLOGY IN OPHTHALMOLOGY AND OTHER FIELDS OF MEDICINE THAT ARE USED IN THE DIAGNOSIS, DOCUMENTATION, TREATMENT, OR GENETIC UNDERSTANDING OF DISEASES. THE FUND MAY OFFER A SCHOLARSHIP TO ASSIST MEDICAL STUDENTS, DOCTORAL STUDENTS, DOCTORS-IN-TRAINING AND NURSES WITH EDUCATIONAL EXPENSES INCURRED ATTENDING COURSES OR CONFERENCES. THE SELECTION CRITERIA WILL BE OBJECTIVE AND NON-DISCRIMINATORY.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PART VI, SECTION A, LINE 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART VI, SECTION A, LINE 8B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PART VI, SECTION B, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PART VI, SECTION B, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART VI, SECTION B, LINE 15
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PART VI, SECTION C, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6FORM 990, PART XII, LINE 2C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc7FORM 990, PART I, LINE 1 & PART III, LINE 1:
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/StatesWhereCopyOfReturnIsFldCd0NY
IRS990/SubjectToExcsTaxNetInvstIncInd00
IRS990/SubjectToProxyTaxInd00
IRS990/SubjToTaxRmnrtnExPrchtPymtInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt0965576
IRS990/TotalAssetsEOYAmt0814715
IRS990/TotalAssetsGrp/BOYAmt0965576
IRS990/TotalAssetsGrp/EOYAmt0814715
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt034922
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt04782
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0247857
IRS990/TotalFunctionalExpensesGrp/TotalAmt0252639
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt099999
IRS990/TotalLiabilitiesEOYAmt070975
IRS990/TotalLiabilitiesGrp/BOYAmt099999
IRS990/TotalLiabilitiesGrp/EOYAmt070975
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0865577
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0743740
IRS990/TotalOtherCompensationAmt00
IRS990/TotalOtherProgSrvcExpenseAmt09354
IRS990/TotalOtherProgSrvcGrantAmt09354
IRS990/TotalProgramServiceExpensesAmt0247857
IRS990/TotalReportableCompFromOrgAmt00
IRS990/TotalRevenueGrp/ExclusionAmt017218
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt052140
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/TotalVolunteersCnt00
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0965576
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0814715
IRS990/TotReportableCompRltdOrgAmt00
IRS990/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd00
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt0101 CENTRAL PARK WEST
IRS990/USAddress/CityNm0NEW YORK
IRS990/USAddress/StateAbbreviationCd0NY
IRS990/USAddress/ZIPCd010023
IRS990/VotingMembersGoverningBodyCnt05
IRS990/VotingMembersIndependentCnt05
IRS990/WebsiteAddressTxt0WWW.FUNDFOROPHTHALMICKNOWLEDGE.ORG
IRS990/WhistleblowerPolicyInd01
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/AuthenticationAssuranceLevelCd0AAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/IdentityAssuranceLevelCd0IAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/TrustedCustomerCd02
ReturnHeader/BuildTS02023-04-26 12:10:37Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0DAVID H ABRAMSON MD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum02127441700
ReturnHeader/BusinessOfficerGrp/SignatureDt02024-05-16
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0FUND FOR OPHTHALMIC KNOWLEDGE INC
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0C/O DAVID H ABRAMSON MD
ReturnHeader/Filer/BusinessNameControlTxt0FUND
ReturnHeader/Filer/EIN0134171637

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.78$0.06$0.72$0.07$0.14$0.07
2023Detailed filing. Detailed filing data is available for this year.$0.81$0.07$0.74$0.05$0.25$0.20
2023Summary only. Only limited summary data is available for this year.$0.81$0.07$0.74$0.05$0.25$0.20
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.97$0.10$0.87$0.10$0.26$0.15
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.30$0.01$1.29$0.18$0.14$0.04
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.22$0.01$1.21$0.07$0.20$0.12
2019Summary only. Only limited summary data is available for this year.$1.28$0.01$1.27$0.16$0.29$0.13
2018Summary only. Only limited summary data is available for this year.$1.27$0.01$1.26$0.21$0.32$0.11
2017Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.55$0.01$1.55$0.21$0.31$0.10
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.55$0.01$1.54$0.17$0.24$0.07
2015Summary only. Only limited summary data is available for this year.$1.61$0.03$1.58$0.42$0.45$0.03
2014Detailed filing. Detailed filing data is available for this year.$1.69$0.00$1.69$0.52$0.26$0.26
2013Detailed filing. Detailed filing data is available for this year.$1.44$0.00$1.44$0.38$0.65$0.27
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.53$0.00$1.53$0.54
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.58$0.00$1.58$0.50
2010Summary only. Only limited summary data is available for this year.$1.74$0.00$1.74$0.48$0.49$0.01